NCT05922748

Brief Summary

The objective of this exploratory study is to elucidate the underlying cerebral mechanisms of cognitive deficits. To achieve this, the investigator will apply functional brain imaging techniques to patients suffering from cognitive deficits due to cerebral lesions. The investigator will employ a "single-case" approach, suitable for studying rare behavioral profiles such as acquired reading disorders (alexia) or visual perception impairments (agnosia). If necessary, the investigator will use multiple non-invasive imaging methods in the same patients, including:

  1. 1.Magnetic Resonance Imaging (structural and functional), renowned for its spatial resolution and the diverse information it provides, and
  2. 2.Electrophysiological methods (MEG and EEG), notable for their temporal resolution.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,500

participants targeted

Target at P75+ for not_applicable

Timeline
9mo left

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Feb 2014Feb 2027

Study Start

First participant enrolled

February 5, 2014

Completed
9.4 years until next milestone

First Submitted

Initial submission to the registry

June 14, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 28, 2023

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 5, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2027

Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

13 years

First QC Date

June 14, 2023

Last Update Submit

April 24, 2026

Conditions

Keywords

neuroimagingcognitive deficitMEGEEGMRI

Outcome Measures

Primary Outcomes (3)

  • MRI (Functional Magnetic Resonance Imaging)

    Brain activation is revealed by measuring signal changes in brain regions. Activations will be determined by comparing conditions and compared to resting periods using analysis techniques.

    13 years

  • MEG (Magnetoencephalography)

    MEG signals reflect changes in the magnetic field evoked by neuronal activity. They are collected and analyzed using specific analysis methods.

    13 years

  • ERPs (Event-Related Potentials)

    EEG signals, referenced to the right mastoid, are digitized at 125 Hz with a low-pass elliptical input filter at 49 Hz.

    13 years

Study Arms (3)

Patient

EXPERIMENTAL

suffering from brain damage

Other: imagingOther: Evoked PotentialsOther: MEGBehavioral: Behavioural tests

healthy control subjects for imaging

ACTIVE COMPARATOR

healthy control subjects for imaging

Other: imagingOther: Evoked PotentialsOther: MEGBehavioral: Behavioural tests

healthy control subjects for purely behavioural studies

ACTIVE COMPARATOR

healthy control subjects for purely behavioural studies

Other: imagingOther: Evoked PotentialsOther: MEGBehavioral: Behavioural tests

Interventions

Behavioural tests will be evaluated.

Patienthealthy control subjects for imaginghealthy control subjects for purely behavioural studies
imagingOTHER

Brain activation is demonstrated by measuring signal changes in brain regions. Activations will be determined by comparison between conditions and in relation to periods of rest

Also known as: MRI
Patienthealthy control subjects for imaginghealthy control subjects for purely behavioural studies

EEG signals, referenced to the right mastoid, were digitised at 125 Hz with an elliptical low-pass input filter at 49 Hz

Patienthealthy control subjects for imaginghealthy control subjects for purely behavioural studies
MEGOTHER

MEG signals reflect changes in magnetic field evoked by changes in neuronal activity

Patienthealthy control subjects for imaginghealthy control subjects for purely behavioural studies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Common criteria for patients and healthy volunteers:
  • Age: 18 years and older
  • Affiliation with a social security system
  • Signed informed consent
  • No psychotropic medication intake in the week prior to the examination, and no alcohol consumption on the eve of the examination (subjects will be instructed to have a good night's sleep before the examination).
  • Specific criteria for patients:
  • \- Patients must present either cerebral lesions (vascular, malformative, tumoral) or traumatic injuries, or a history of neonatal or congenital conditions that may result in selective cognitive impairments, or congenital or acquired visual perception disorders.
  • Common criteria for patients and volunteers:
  • Pregnant, lactating, or postpartum women (except for purely behavioral tests).
  • Individuals with visual or auditory deficits that would interfere with the tasks to be performed during brain imaging acquisition.
  • Contraindications for MRI (except for purely behavioral tests):
  • Cardiac or neural stimulation devices
  • Ferromagnetic surgical clips
  • Cochlear implants
  • Intra-ocular metallic foreign bodies or objects in the nervous system
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ICM - Paris Brain Institute

Paris, Île-de-France Region, 75013, France

Location

MeSH Terms

Conditions

Cognition Disorders

Interventions

X-RaysEvoked Potentials

Condition Hierarchy (Ancestors)

Neurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electromagnetic RadiationElectromagnetic PhenomenaMagnetic PhenomenaPhysical PhenomenaRadiationRadiation, IonizingCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: We will study patients (n= 300) suffering from focal brain lesions and healthy control subjects (n= 600 for imaging, n= 600 for purely behavioural studies)
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2023

First Posted

June 28, 2023

Study Start

February 5, 2014

Primary Completion (Estimated)

February 5, 2027

Study Completion (Estimated)

February 5, 2027

Last Updated

April 29, 2026

Record last verified: 2026-04

Locations